Controlled Release & Drug Delivery Symposium 2014 (CRDDS2014)
Researchers in pharmacy and drug delivery met on UKM's Kuala Lumpur Campus for two days of talks under the theme "Maximizing Efficacy Through Optimized Delivery". Prima Nexus was one of the supporters.
· Symposium · Supported by Prima Nexus
About the symposium
The Centre for Drug Delivery Research at the Faculty of Pharmacy, Universiti Kebangsaan Malaysia (UKM), hosted CRDDS2014 on Saturday 23 and Sunday 24 August 2014, in lecture halls DK2 and DK3 on the UKM Kuala Lumpur Campus. It was held in conjunction with the annual general meeting of the Malaysian Local Chapter of the Controlled Release Society (MyCRS), and its theme was "Maximizing Efficacy Through Optimized Delivery".
What the symposium covered
The symposium set out to share recent research and advances in the pharmaceutical sciences. Its topics included new approaches to drug delivery, modified-release systems, sterile and injectable formulations, natural and synthetic polymers, the delivery of peptides, proteins, DNA and genes, other routes into the body, biopharmaceutical and pharmacokinetic studies, the design of dosage forms, pharmaceutical manufacturing, and the safety and stability of medicines. The photographs show the delegates' group photo in front of the title slide, and presentations on the stage.
Prima Nexus's part
Prima Nexus was one of the supporters of CRDDS2014, at the invitation of the organising committee. In December 2014 it supported a seminar for MyCRS members at the same Centre for Drug Delivery Research, and a year later it supported CRDDS2015. Drug delivery teams that need to test a new formulation in rats or mice can work with Prima Nexus on in vivo animal studies.
More of our work with UKM.
Read the story: Prima Nexus supported meetings on cancer, microscopy, pharmacology, drug delivery and tissue engineering in 2014.
About Prima Nexus
Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. We also run hands-on training for researchers across Malaysia. More about Prima Nexus.
